SOURCE: Scottsdale Neuropathy Institute

Scottsdale Neuropathy Institute

February 22, 2010 15:47 ET

Dr. Richard Jacoby to Address Nearly 1,000 Physicians at International Congress XXIII Endovascular Interventions -- March 2, 2010

Preliminary Findings of Breakthrough Study Show Promising Link Between Reduced Blood Flow and Amputations

SCOTTSDALE, AZ--(Marketwire - February 22, 2010) -  Dr. Richard Jacoby, DPM, of the Scottsdale Neuropathy Institute, will present the preliminary findings of a ground breaking blood flow study to the International Congress XXIII during its annual meeting February 28 through March 4 at Scottsdale's Phoenician Resort.

'The Neurovascular Evaluation of the Triple Nerve Release of the Lower Extremities,' is expected to provide a greater understanding of the impact of blood flow in diabetic neuropathy. The study is a joint collaboration with the Arizona Heart Institute (AHI), with Dr. Jacoby conducting the study and Dr. Venkatesh G. Ramaiah, of the Arizona Heart Institute, evaluating the blood flow rates. This is the first formal study conducted that investigates the link between neuropathy and blood flow.

"Blood flow is the missing link to why patients are losing legs," Jacoby said. "This study is the first step to solving the riddle of why people with diabetes end up with amputations."

Dr. Jacoby will present the study's preliminary results in diabetic patients to an audience of 1,000 physicians at 10 a.m., on March 2, 2010. The study's preliminary outlook is promising, showing that recovery is dramatic for patients who undergo the Dellon Decompression triple nerve release surgical procedure. These patients experience significant improvement and increased blood flow to damaged nerves, with improved sensation and reduction of pain.

"More than 10,000 amputations are performed each month in the United States," Dr. Ramaiah said. "This work will help to lower the amputation rate in diabetic patients." 

Studies show that diabetes-related amputations cost approximately three billion dollars per year ($38,077 per amputation procedure). With the rise of diabetes diagnoses, there is also an expected rise in the number of amputees. According to the Center for Disease Control (CDC), the total estimated diabetes costs in the United States in 2007 was $174 billion, making diabetes one of the most costly Medicare expenses. Two-thirds of all lower extremity amputations in the United States were directly linked to diabetes. In addition, two-thirds of these amputations were paid for by the Medicare program. 

The findings presented by this study will be useful to endovascular specialists (podiatrists, vascular surgeons, and neurosurgeons) who treat diabetic neuropathy. See www.endovascularcongress.org for more information.

About Diabetes and Neuropathy
Diabetes was the seventh leading cause of death in 2006, according to the CDC. More than 23 million people suffer from diabetes. This debilitating disease can lead to serious complications, such as cardiovascular disease and lower-limb amputations. For nearly 35 years, Scottsdale Neuropathy Institute remains one of the world's leading providers dedicated to the prevention, diagnosis, and treatment of diabetic neuropathy and offers the most contemporary approach to reducing the number of amputations among diabetic patients. For more information on the Scottsdale Neuropathy Institute, visit www.neuropathyweb.com.

Contact Information

  • Media Contact:
    Raquel Baldelomar
    Quaintise, LLC
    Phone: (602) 820-4563
    Email:Email Contact